Monday, August 15, 2022

Accelerate Diagnostics Q2 Net Loss Narrows

Vitro diagnostics company Accelerate Diagnostics, Inc. (AXDX) announced Monday that net loss for the second quarter narrowed to $17.80 million or $0.23 per share from $21.67 million or $0.36 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/CAFcOka
via IFTTT

No comments:

Post a Comment